论文部分内容阅读
2008年6月26日.广州市天河区人民法院对“齐二药”假药系列案件做出一审宣判.判定齐齐哈尔第二制药有限公司(以下简称齐二药公司)承担最终赔偿责任,中山大学附属第三医院(以下简称中山三院)等其余3方被告承担连带责任.共需赔偿原告350万元。此判决宣布后,中山三院等被告不服判决,当即表示将上诉,原告对判决也不满意。天河法院的判决是否合情、合理以及合法?此事件将给各个医院的管理提供哪些经验、教训和警示?专家们如是说。
June 26, 2008. Guangzhou Tianhe District People’s Court made a first instance verdict on the “Qi Two Drugs” series of counterfeit medicines and decided that Qiqihar Second Pharmaceutical Co., Ltd. (hereinafter referred to as Qi Er Medicine Co., Ltd.) assumed the ultimate liability for compensation, Sun Yat-sen Affiliated Third Hospital (hereinafter referred to as Zhongshan Hospitals) and other three defendants bear joint and several liability. After the verdict was announced, the defendants such as Zhongshan Hospitals refused to accept the verdict and immediately said they would appeal. The plaintiff was not satisfied with the verdict. Whether the judgment of Tianhe Court is fair, reasonable and legal? What experiences, lessons and warnings will be given to the management of each hospital? The experts said.